Bufrolin

This classification denotes a mast cell stabilizer with the molecular formula C18H16N2O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 46C1PX266N, chemically known as 6-butyl-1,4,7,10-tetrahydro-4,10-dioxo-1,7-phenanthroline-2,8-dicarboxylic acid but generally known as bufrolin, which bears US NIH Compound Identifier 72103. European Medicines Agency schedules Bufrolin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05966MIG. The term BUFROLIN is an International Non-Proprietary Name. BUFROLIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule bufrolin under HS 29339990 and SITC 51577. As of Q4 2014, BUFROLIN remains the US FDA Preferred Term for this commodity. Bufrolin bears US NLM identifiers UMLS ID C0054211 and NCI Concept Code C72940. SMILES: O=C1C2C([NH]C(C1)C(=O)O)C(CCCC)CC1C2[NH]C(CC1=O)C(=O)O.